Menu
Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3
Review
Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,509 | Dovepress* | 11,179+ | 4,572 | 15,751 | |
| PubMed Central* | 2,330 | 130 | 2,460 | ||
| Totals | 13,509 | 4,702 | 18,211 | ||
|
*Since 4 August 2011 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar